MRVI Competitors & Alternatives
Compare Maravai Lifesciences Holdings Inc with similar stocks in the same industry
Biotechnology
MRVI
Main Stock$7.57
Tradestie Score
59
Market Cap
$454.29M
Revenue Growth
0.1%
Analyst Upside
+12.3%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
APLS
Apellis Pharmaceuticals, Inc. Common Stock
|
$41.03
|
$2.92B | 38.3 | 50 | Compare |
|
RARE
Ultragenyx Pharmaceutical Inc.
|
$15.92
|
$2.89B | - | 39 | Compare |
|
IMVT
Immunovant, Inc. Common Stock
|
$28.38
|
$2.85B | - | 54 | Compare |
|
CPRX
Catalyst Pharmaceutical Inc.
|
$31.49
|
$2.56B | 18.2 | 51 | Compare |
|
CDTX
Cidara Therapeutics, Inc.
|
$221.38
|
$2.44B | - | 50 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$24.39
|
$2.44B | - | 62 | Compare |
|
TARS
Tarsus Pharmaceuticals, Inc. Common Stock
|
$70.50
|
$2.42B | - | 64 | Compare |
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$153.18
|
$2.41B | - | 71 | Compare |
|
IDYA
IDEAYA Biosciences, Inc. Common Stock
|
$35.47
|
$2.40B | - | 65 | Compare |
|
FOLD
Amicus Therapeutics, Inc
|
$14.49
|
$2.38B | - | 52 | Compare |
More MRVI Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
224 stocks in this industry